Optivia Biotechnology and Hurel Corporation jointly announced that they have formalized a technology and marketing alliance. Under the companies’ agreement, Hurel’s new, patent-pending HμRELflux™ ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced that the company and the University of California, San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results